EUVIMEDEUVIMED entdecken
Crossref

Xpert MTB/XDR assay: rapid TB drug resistance detection

Sunil Sethi, Shelly Sharma, Ashutosh N Aggarwal, Sunil Kumar Dhatwalia, Rajesh Rana, Rakesh Yadav

Infection · 2024-12 · 52 (6) · 2207-2212

DOI: 10.1007/s15010-024-02260-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection, online erschienen am 06.05.2024. Verfasst von Sunil Sethi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India. sunilsethi10@hotmail.com. Hauptthemen laut MEDLINE: Antitubercular Agents, Mycobacterium tuberculosis, Microbial Sensitivity Tests, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To assess the Xpert MTB/XDR assay's efficiency in promptly detecting resistance to isoniazid, fluoroquinolones, ethionamide, and second-line injectable drugs among tuberculosis (TB) patients. METHODS: From August 2020 to July 2021, TB suspected patient samples were enrolled at a tertiary care center for our study. We conducted mycobacterial culture, phenotypic DST using proportion method in liquid culture at WHO-recommended concentrations, and the line probe assay (LPA). Simultaneously, the Index test, Xpert MTB/XDR, was performed following the manufacturer's instructions. RESULTS: Among 360 samples, 107 were excluded due to incomplete information. Resistance to isoniazid, levofloxacin and moxifloxacin was found in 45/251, 21/251 and 20/251 samples, respectively by phenotypic DST. The diagnostic accuracy of Index test, taking phenotypic DST as a reference standard, was 95.8%, 99.04%, and 99.05% for isoniazid, levofloxacin, and moxifloxacin, respectively. The Index test assay demonstrated a specificity of 99.1% for detecting SLID resistance, yielding a diagnostic accuracy of 99.2. Comparing the Index test with LPA revealed a significant enhancement in sensitivity for detecting isoniazid resistance (86.7% vs. 82.2%). CONCLUSIONS: The Index test exhibited promising outcomes in identifying resistance to isoniazid and fluoroquinolones, surpassing the performance of the LPA. This could be valuable for promptly initiating treatment in cases of drug-resistant tuberculosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsMycobacterium tuberculosisMicrobial Sensitivity TestsTuberculosis, Multidrug-ResistantHumansFemaleAdultMaleSensitivity and SpecificityMiddle AgedExtensively Drug-Resistant TuberculosisDrug Resistance, Multiple, BacterialYoung Adult

Stichwörter der Autor:innen

Drug resistanceFQsMolecular diagnosisSLIDTuberculosis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India. sunilsethi10@hotmail.com.
  • Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
  • Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • State TB Cell, Chandigarh, India.

Zitieren

APA

Sethi, S., Sharma, S., Aggarwal, A. N., Dhatwalia, S. K., Rana, R., & Yadav, R. (2024). Xpert MTB/XDR assay: rapid TB drug resistance detection. Infection, 52(6), 2207-2212. https://doi.org/10.1007/s15010-024-02260-7

Vancouver

Sethi S, Sharma S, Aggarwal AN, Dhatwalia SK, Rana R, Yadav R. Xpert MTB/XDR assay: rapid TB drug resistance detection. Infection. 2024;52(6):2207-2212. doi:10.1007/s15010-024-02260-7

BibTeX
@article{Sethi2024,
  author = {Sethi, Sunil and Sharma, Shelly and Aggarwal, Ashutosh N and Dhatwalia, Sunil Kumar and Rana, Rajesh and Yadav, Rakesh},
  title = {Xpert MTB/XDR assay: rapid TB drug resistance detection},
  journal = {Infection},
  year = {2024},
  volume = {52},
  number = {6},
  pages = {2207--2212},
  doi = {10.1007/s15010-024-02260-7}
}
Kostenlos starten →